CTNS mutations in an American-based population of cystinosis patients.

Nephropathic cystinosis is an autosomal recessive lysosomal storage disease characterized by renal failure at 10 years of age and other systemic complications. The gene for cystinosis, CTNS, has 12 exons. Its 2.6-kb mRNA codes for a 367-amino-acid putative cystine transporter with seven transmembran...

Full description

Bibliographic Details
Main Authors: Shotelersuk, V, Larson, D, Anikster, Y, McDowell, G, Lemons, R, Bernardini, I, Guo, J, Thoene, J, Gahl, W A
Format: Text
Language:English
Published: 1998
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1377545
http://www.ncbi.nlm.nih.gov/pubmed/9792862
id ftpubmed:oai:pubmedcentral.nih.gov:1377545
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:1377545 2023-05-15T16:51:28+02:00 CTNS mutations in an American-based population of cystinosis patients. Shotelersuk, V Larson, D Anikster, Y McDowell, G Lemons, R Bernardini, I Guo, J Thoene, J Gahl, W A 1998-11 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1377545 http://www.ncbi.nlm.nih.gov/pubmed/9792862 en eng http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1377545 http://www.ncbi.nlm.nih.gov/pubmed/9792862 Research Article Text 1998 ftpubmed 2013-08-30T21:32:52Z Nephropathic cystinosis is an autosomal recessive lysosomal storage disease characterized by renal failure at 10 years of age and other systemic complications. The gene for cystinosis, CTNS, has 12 exons. Its 2.6-kb mRNA codes for a 367-amino-acid putative cystine transporter with seven transmembrane domains. Previously reported mutations include a 65-kb "European" deletion involving marker D17S829 and 11 small mutations. Mutation analysis of 108 American-based nephropathic cystinosis patients revealed that 48 patients (44%) were homozygous for the 65-kb deletion, 2 had a smaller major deletion, 11 were homozygous and 3 were heterozygous for 753G-->A (W138X), and 24 had 21 other mutations. In 20 patients (19%), no mutations were found. Of 82 alleles bearing the 65-kb deletion, 38 derived from Germany, 28 from the British Isles, and 4 from Iceland. Eighteen new mutations were identified, including the first reported missense mutations, two in-frame deletions, and mutations in patients of African American, Mexican, and Indian ancestry. CTNS mutations are spread throughout the leader sequence, transmembrane, and nontransmembrane regions. According to a cystinosis clinical severity score, homozygotes for the 65-kb deletion and for W138X have average disease, whereas mutations involving the first amino acids prior to transmembrane domains are associated with mild disease. By northern blot analysis, CTNS was not expressed in patients homozygous for the 65-kb deletion but was expressed in all 15 other patients tested. These data demonstrate the origins of CTNS mutations in America and provide a basis for possible molecular diagnosis in this population. Text Iceland PubMed Central (PMC) Indian
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Research Article
spellingShingle Research Article
Shotelersuk, V
Larson, D
Anikster, Y
McDowell, G
Lemons, R
Bernardini, I
Guo, J
Thoene, J
Gahl, W A
CTNS mutations in an American-based population of cystinosis patients.
topic_facet Research Article
description Nephropathic cystinosis is an autosomal recessive lysosomal storage disease characterized by renal failure at 10 years of age and other systemic complications. The gene for cystinosis, CTNS, has 12 exons. Its 2.6-kb mRNA codes for a 367-amino-acid putative cystine transporter with seven transmembrane domains. Previously reported mutations include a 65-kb "European" deletion involving marker D17S829 and 11 small mutations. Mutation analysis of 108 American-based nephropathic cystinosis patients revealed that 48 patients (44%) were homozygous for the 65-kb deletion, 2 had a smaller major deletion, 11 were homozygous and 3 were heterozygous for 753G-->A (W138X), and 24 had 21 other mutations. In 20 patients (19%), no mutations were found. Of 82 alleles bearing the 65-kb deletion, 38 derived from Germany, 28 from the British Isles, and 4 from Iceland. Eighteen new mutations were identified, including the first reported missense mutations, two in-frame deletions, and mutations in patients of African American, Mexican, and Indian ancestry. CTNS mutations are spread throughout the leader sequence, transmembrane, and nontransmembrane regions. According to a cystinosis clinical severity score, homozygotes for the 65-kb deletion and for W138X have average disease, whereas mutations involving the first amino acids prior to transmembrane domains are associated with mild disease. By northern blot analysis, CTNS was not expressed in patients homozygous for the 65-kb deletion but was expressed in all 15 other patients tested. These data demonstrate the origins of CTNS mutations in America and provide a basis for possible molecular diagnosis in this population.
format Text
author Shotelersuk, V
Larson, D
Anikster, Y
McDowell, G
Lemons, R
Bernardini, I
Guo, J
Thoene, J
Gahl, W A
author_facet Shotelersuk, V
Larson, D
Anikster, Y
McDowell, G
Lemons, R
Bernardini, I
Guo, J
Thoene, J
Gahl, W A
author_sort Shotelersuk, V
title CTNS mutations in an American-based population of cystinosis patients.
title_short CTNS mutations in an American-based population of cystinosis patients.
title_full CTNS mutations in an American-based population of cystinosis patients.
title_fullStr CTNS mutations in an American-based population of cystinosis patients.
title_full_unstemmed CTNS mutations in an American-based population of cystinosis patients.
title_sort ctns mutations in an american-based population of cystinosis patients.
publishDate 1998
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1377545
http://www.ncbi.nlm.nih.gov/pubmed/9792862
geographic Indian
geographic_facet Indian
genre Iceland
genre_facet Iceland
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1377545
http://www.ncbi.nlm.nih.gov/pubmed/9792862
_version_ 1766041586887557120